Patents by Inventor Frédéric Leroy

Frédéric Leroy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200162017
    Abstract: A photovoltaic panel is provided, including a plastic support sheet having a cellular core; a laminate of photovoltaic cells fixed to the support sheet; and a plastic and/or composite frame including longitudinal profile sections for laterally protecting the laminate of photovoltaic cells and the support sheet, and corner-shaped portions connecting the longitudinal profile sections together in order therewith to form a closed frame.
    Type: Application
    Filed: June 28, 2018
    Publication date: May 21, 2020
    Applicant: TOTAL SOLAR
    Inventors: Valerick CASSAGNE, Jean Guillaume LOBJOIS, Frederic LEROY
  • Patent number: 9284307
    Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: March 15, 2016
    Assignee: Idenix Pharmaceuticals LLC
    Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Frederic Leroy, Thierry Convard, Dominique Surleraux
  • Patent number: 9186369
    Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: November 17, 2015
    Assignee: Idenix Pharmaceuticals, LLC
    Inventors: Richard Storer, Gilles Gosselin, David Dukhan, Frederic Leroy
  • Patent number: 8993595
    Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: March 31, 2015
    Assignee: Idenix Pharmaceuticals, Inc.
    Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Michel Derock, Frederic Leroy, Jean-Christophe Meillon, Thierry Convard, Dominique Surleraux
  • Publication number: 20140234251
    Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.
    Type: Application
    Filed: May 2, 2014
    Publication date: August 21, 2014
    Applicants: Indenix Pharmaceuticals, Inc., The Centre National de la Recherche Scientifique, L'Universite Montpellier II
    Inventors: Richard STORER, Gilles GOSSELIN, David DUKHAN, Frederic LEROY
  • Patent number: 8742101
    Abstract: This invention is directed to a method for treating a host, especially a human, infected with hepatitis C, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-HCV biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents.
    Type: Grant
    Filed: November 13, 2008
    Date of Patent: June 3, 2014
    Assignees: Idenix Pharmaceuticals, Inc., Centre National de la Recherche Scientifique, L'Universite Montpellier II
    Inventors: Richard Storer, Gilles Gosselin, David Dukhan, Frederic Leroy
  • Patent number: 8697548
    Abstract: A method for making a semi-conductor nanocrystals, including at least the steps of: making a stack of at least one uniaxially stressed semi-conductor thin layer and a dielectric layer, annealing the semi-conductor thin layer such that a dewetting of the semi-conductor forms, on the dielectric layer, elongated shaped semi-conductor nanocrystals oriented perpendicularly to the stress axis.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: April 15, 2014
    Assignees: Commissariat a l'energie atomique et aux energies alternatives, Centre National de la Recherche Scientifique
    Inventors: Lukasz Borowik, Jean-Charles Barbe, Ezra Bussmann, Fabien Cheynis, Frédéric Leroy, Denis Mariolle, Pierre Müller
  • Patent number: 8647957
    Abstract: A method for making semi-conductor nanocrystals, including at least the steps of: forming solid carbon chemical species on a semi-conductor thin layer provided on at least one dielectric layer, the dimensions and the density of the carbon chemical species formed on the semi-conductor thin layer being a function of the desired dimensions and density of the semi-conductor nanocrystals; annealing the semi-conductor thin layer, performing a dewetting of the semi-conductor and forming, on the dielectric layer, the semi-conductor nanocrystals.
    Type: Grant
    Filed: May 4, 2012
    Date of Patent: February 11, 2014
    Assignees: Commissariat à l'énergie atomique et aux énergies alternatives, Centre National de la Recherche Scientifique
    Inventors: Lukasz Borowik, Jean-Charles Barbe, Ezra Bussmann, Fabien Cheynis, Frederic Leroy, Denis Mariolle, Pierre Muller
  • Patent number: 8609076
    Abstract: The present invention relates to the use of polyols of formula (I): or a salt thereof, for preventing the hair from breaking. The invention also relates to a cosmetic composition comprising at least one such polyol or a salt thereof, in a cosmetically acceptable medium, and also to a cosmetic hair treatment process using the said composition.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: December 17, 2013
    Assignee: L'Oreal
    Inventors: Frederic Leroy, Michel Philippe, Philippe Barbarat, Christian Blaise
  • Patent number: 8377962
    Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
    Type: Grant
    Filed: April 7, 2010
    Date of Patent: February 19, 2013
    Assignee: Idenix Pharmaceuticals, Inc.
    Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Michel Derock, Frederic Leroy, Jean-Christophe Meillon, Thierry Convard, Dominique Surleraux
  • Patent number: 8379015
    Abstract: The invention relates to a method of generating a synthesized image of a hair, comprising the following steps: calculating the shape of the hair by applying a behavioral relationship determining the shape of the hair as a function of a physical parameter linked to a mechanical property of the hair, in particular the linear density; producing an image of the hair of shape that has been calculated in this way.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: February 19, 2013
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Jean-Luc Leveque, Basile Audoly, Frederic Leroy, Bernard Querleux
  • Publication number: 20120282758
    Abstract: A method for making semi-conductor nanocrystals, including at least the steps of: forming solid carbon chemical species on a semi-conductor thin layer provided on at least one dielectric layer, the dimensions and the density of the carbon chemical species formed on the semi-conductor thin layer being a function of the desired dimensions and density of the semi-conductor nanocrystals; annealing the semi-conductor thin layer, performing a dewetting of the semi-conductor and forming, on the dielectric layer, the semi-conductor nanocrystals.
    Type: Application
    Filed: May 4, 2012
    Publication date: November 8, 2012
    Applicants: Centre National De La Recherche Scientifique, Commissariat a L'Energie Atomique Et Aux Ene Alt
    Inventors: Lukasz BOROWIK, Jean-Charles Barbe, Ezra Bussmann, Fabien Cheynis, Frédéric Leroy, Denis Mariolle, Pierre Müller
  • Publication number: 20120282759
    Abstract: A method for making a semi-conductor nanocrystals, including at least the steps of: making a stack of at least one uniaxially stressed semi-conductor thin layer and a dielectric layer, annealing the semi-conductor thin layer such that a dewetting of the semi-conductor forms, on the dielectric layer, elongated shaped semi-conductor nanocrystals oriented perpendicularly to the stress axis.
    Type: Application
    Filed: May 4, 2012
    Publication date: November 8, 2012
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT
    Inventors: Lukasz BOROWIK, Jean-Charles BARBE, Ezra BUSSMANN, Fabien CHEYNIS, Frédéric LEROY, Denis MARIOLLE, Pierre Müller
  • Patent number: 8193372
    Abstract: Provided herein are phosphothiophene and phosphothiazole compounds, for example, of any of Formulae I, IA, IIA, IIIA, IVA, VA, VIA, VIIA, IB, IIB, IIIB, IVB, VB, VIB and VIIB disclosed herein, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host infected with HCV.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: June 5, 2012
    Assignee: Idenix Pharmaceuticals, Inc.
    Inventors: Cyril Dousson, Claire Pierra, Jean-Francois Griffon, Frederic Leroy, Jean-Laurent Paparin, David Dukhan, Dominique Surleraux
  • Patent number: 8026911
    Abstract: The invention relates to a method of generating a synthesized image of a hair, comprising the following steps: calculating the shape of the hair by applying a behavioral relationship determining the shape of the hair as a function of a physical parameter linked to a mechanical property of the hair, in particular the linear density; producing an image of the hair of shape that has been calculated in this way.
    Type: Grant
    Filed: March 19, 2007
    Date of Patent: September 27, 2011
    Assignee: L'Oreal
    Inventors: Jean-Luc Leveque, Basile Audoly, Frederic Leroy, Bernard Querleux
  • Publication number: 20110205225
    Abstract: The invention relates to a method of generating a synthesized image of a hair, comprising the following steps: calculating the shape of the hair by applying a behavioral relationship determining the shape of the hair as a function of a physical parameter linked to a mechanical property of the hair, in particular the linear density; producing an image of the hair of shape that has been calculated in this way.
    Type: Application
    Filed: April 29, 2011
    Publication date: August 25, 2011
    Applicant: L'Oreal
    Inventors: Jean-Luc Leveque, Basile Audoly, Frederic Leroy, Bernard Querleux
  • Patent number: 8003659
    Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
    Type: Grant
    Filed: February 3, 2009
    Date of Patent: August 23, 2011
    Assignee: Indenix Pharmaceuticals, Inc.
    Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Dominique Surleraux, Michel Derock, Frederic Leroy
  • Publication number: 20110129443
    Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
    Type: Application
    Filed: August 4, 2010
    Publication date: June 2, 2011
    Applicant: Idenix Pharmaceuticals, Inc.
    Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Frederic Leroy, Thierry Convard, Dominique Surleraux
  • Publication number: 20100260710
    Abstract: Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
    Type: Application
    Filed: April 7, 2010
    Publication date: October 14, 2010
    Applicant: Idenix Pharmaceuticals, Inc.
    Inventors: Christophe Claude Parsy, Francois-Rene Alexandre, Michel Derock, Frederic Leroy, Jean-Christophe Meillon, Thierry Convard, Dominique Surleraux
  • Publication number: 20100233123
    Abstract: Provided herein are phosphothiophene and phosphothiazole compounds, for example, of any of Formulae I, IA, IIA, IIIA, IVA, VA, VIA, VIIA, IB, IIB, IIIB, IVB, VB, VIIB and VIIB disclosed herein, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host infected with HCV.
    Type: Application
    Filed: March 3, 2010
    Publication date: September 16, 2010
    Applicant: Idenix Pharmaceuticals, Inc.
    Inventors: Cyril Dousson, Claire Pierra, Jean-Francois Griffon, Frederic Leroy, Jean-Laurent Paparin, David Dukhan, Dominique Surleraux